FUJIAN COSUNTER PHARMACEUTICAL CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 18.71 CNY | +4.29% |
|
+6.61% | -27.00% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
Fujian Cosunter Pharmaceutical Co., Ltd. is a China-based company principally engaged in the research, development, manufacture and sales of nucleoside anti-HBV drugs. The Company's major products include Adefovir Dipivoxil Tablets, Lamivudine Tablets, Entecavir Capsules and other nucleoside anti-HBV drugs. The Company also produces over-the-counter (OTC) drugs, such as ferrous fumarate and ganoderma capsules.
Sector
Pharmaceuticals
Calendar
2024-05-13
- Annual General Meeting
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -27.00% | 413M | |
| +31.52% | 690B | |
| +24.81% | 546B | |
| -5.21% | 358B | |
| +17.02% | 323B | |
| +5.01% | 287B | |
| +14.13% | 235B | |
| +5.22% | 199B | |
| -9.98% | 195B | |
| +3.98% | 161B |
- Stock Market
- Equities
- 300436 Stock
- News Fujian Cosunter Pharmaceutical Co., Ltd.
- Fujian Cosunter Pharma Selling 948 Million Yuan Shares to Fund New Drug Research Platform